Gabrielle Mykoniatis MD - Matteson, Illinois 60443

Gabrielle Mykoniatis MD is categorized under Doctors in Matteson, IL .

Business Name: Gabrielle Mykoniatis MD
Contact Person: gabrielle mykoniatis
Address: 20939 S Cicero Ave, Matteson, Illinois 60443
Phone Number: (708) 679-2770
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
Share This Business:
Related Businesses: Patel Neela MD - Matteson, IL 60443
Sherwin Ho - Matteson, IL 60443
Hameeduddin Anjum MD - Matteson, IL 60443
Alli-Balogun Sherriff A MD - Matteson, IL 60443
Hameeduddin Ann MD - Matteson, IL 60443
Rovinson Leonard MD - Matteson, IL 60443
Wellgroup Healthpartners - Matteson, IL 60443
Cansler Health Associates S C - Matteson, IL 60443
Med Centrix Inc - Matteson, IL 60443
Bhatia Motilal MD - Matteson, IL 60443
Durr Robert D DDS - Matteson, IL 60443
Davita Olympia Fields Hhd - Matteson, IL 60443
Dr Heart Scan LLC - Matteson, IL 60443
Patel Sunil MD - Matteson, IL 60443
Afroz Nayyar MD - Matteson, IL 60443
Schultz Gordon MD - Matteson, IL 60443
Maclaren Joyce MD - Matteson, IL 60443
Dzudza Eldin MD - Matteson, IL 60443
Hollandsworth Don L DO - Matteson, IL 60443
True Care Visiting Physician - Matteson, IL 60443

The company Gabrielle Mykoniatis MD provides B2C services in the form of Doctors from its single location in Illinois. 1 to 4 employees work for Gabrielle Mykoniatis MD, and the business now earns $500.000 to $999.999 per annum.

Gabrielle Mykoniatis MD was launched in 0 and is classified under SIC code and category , and NAICS number and grouping . To contact Gabrielle Mykoniatis MD, please call gabrielle mykoniatis with the phone number (708) 679-2770 or visit its single location at 20939 S Cicero Ave in Matteson, Illinois 60443.

The location of the single location can also be found using the coordinates 41.89355,-87.62451. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.